18个独家品种太猛了!潜力新药暴涨7036%,石药、先声、华润满载而归,61款1类新药来袭

米内网
Jan 19

精彩内容在政策及人口因素的驱动下,实体药店愈发成为神经系统用药关键销售渠道。米内网数据显示,2025Q1~Q3中国重点省份实体药店市场神经系统用药销售额近70亿元;西药(化药+生物药,下同)品牌TOP20中,石药的丁苯酞软胶囊稳居榜首,先声的潜力新药暴涨7036%;中成药品牌TOP20中,14个独家品种(含剂型独家,下同)上榜,敖东、上药、华润等表现亮眼。在研新品布局上,海思科、恒瑞、正大制药...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10